5/31/2013

Syntermed has received FDA 510(k) clearance for upgraded NeuroQ nuclear medicine software, which can be used to evaluate amyloid accumulation in the brain. The software is designed to assess the distribution of imaging agents in PET images and can compare two images from the same patient.

Related Summaries